Inovio Pharmaceuticals (INO) CFO exercises 4,771 RSUs and has 2,571 shares withheld for taxes
Rhea-AI Filing Summary
INOVIO PHARMACEUTICALS, INC. CFO Peter Kies reported routine equity compensation activity involving restricted stock units. On May 15, 2026, 4,771 restricted stock units were exercised and converted into an equal number of common shares, consistent with a vesting schedule covering 14,313 units.
In a related transaction that day, 2,571 common shares were withheld by the issuer at $1.30 per share to satisfy Kies’s tax withholding obligations tied to this vesting and settlement. These tax-withholding shares were not an open-market sale.
Following these transactions, Kies directly holds 38,842 common shares, and his spouse indirectly holds an additional 375 common shares reported as indirect ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 4,771 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,771 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 2,571 | $1.30 | $3K |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- F2. The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
Key Figures
Key Terms
Restricted Stock Unit financial
vesting schedule financial
tax withholding obligations financial
derivative security financial
AI-generated analysis. How Rhea-AI works. Not financial advice.